Artia Global Partners LP Roivant Sciences Ltd. Transaction History

Artia Global Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $875,081 - $1.18 Million	89,660 Added 10.88%	914,023 $10.7 Billion
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $4.73 Million - $6.72 Million	666,600 Added 422.53%	824,363 $8.31 Billion
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $1.09 Million - $1.57 Million	157,763 New	157,763 $1.16 Billion

314

495M

1.29M

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

Stay updated on Artia Global Partners LP with notifications on news.